Hemoglobin A1c: Past, present and future

Annals of Saudi Medicine

Volumn 28, Issue 6, 2008, Pages 411-419

  Aldasouqi, Saleh A ^a,b,c   Gossain, Ved V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Department of Medicine   (United States)

^c FACP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; GLYCOSYLATED HEMOGLOBIN;

DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOASSAY; NOMENCLATURE; PRACTICE GUIDELINE; REVIEW; STANDARD;

DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOASSAY; PRACTICE GUIDELINES AS TOPIC; TERMINOLOGY AS TOPIC;

EID: 59849112805     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.51670     Document Type: Review

References (82)

1. Chiasson JL. Prevention of Type 2 diabettes: Fact or fiction? Expert Opin Pharmacother 2007;8(18):3147-58.
2. Nathan D, Davidson M, Defrenzo R, Heine R, Henry R, Pratley R, Zinman B. Impaired fasting glucose and Impaired glucose tolerance: Implicattions for care [Consensus Statement: Reviews/commentaries/ADA Statements]. Diabetes Care 2007;30(3):753-9.
3. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: The current status on definition and intervention. Diabet Med 2002;19(9):708-23.
4. Schneider HG, Goodall I, Colman PG, McLean M, Barker G. New haemoglobin A1c: the way it is reported is about to change. Int Med J 2007;37:213- 215.
5. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabetic Med 2007;24:333-43.
6. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. J Clin Endocrinol Metab 2008;93:2447-53.
7. Bryson CL, Boyko EJ. Review: glycated haemogglobin A1c and fasting plasma glucose screening tests have similar sensitivities and specifities for early detection of type 2 diabetes. Evid Based Med 2007;12:152.
8. Miedema K. Standardization of HbA1c and Optimmal Range of Monitoring. Scand J Clin Lab Invest Suppl 2005;240:61-72
9. The 2006 NGSP Clinical Advisory Committee Meeting. ADA 66th Annual Meeting. [accessed 2007 December 16]. Available from: http://www.ngsp.org/prog/ News/CAC2006.htm.
10. Little RR and Rohlfing CL Proposed changes for reporting HbA1c: Various groups are deciding how HbaA1c results are to be reported in the future. In Vitro Diagnost Technol 2007 May. 18 p. [accessed 15 December 2007]. Available from: http://www.devicelink.com/ivdt/archive/07/05/007.html.
11. National Glycohemoglobin Standardization Program. The relationship between GHB and blood glucose. [accessed 16 December 2007]. Available from: http://www.ngsp.org/prog/index.html
12. Davidson MB. Glycosylated hemoglobin as a diagnostic test for Type 2 diabetes mellitus (Lettters). JAMA 2000;283;606.
13. Tahara Y. On the weighted-average relationsship between plasma glucose and HbA1c. Diabettes Care 2006;29:466-7.
14. Trevino G. On the weighted-average relationsship between plasma glucose and HbA1c. Diabettes Care 2006;29:466.
15. Service FJ and O'Brien PC. Influence of glycemmic variables on hemoglobin A1c. Endcorin Pract 2007;13:350-4.
16. The Diabetes Control and Complications Trial Research Group. "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insullin- Dependent Diabetes Mellitus. N Engl J Med 1993;329:977-986.
17. UK Prospective Diabetes Study (UKPDS) Group. Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Convventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). The Lancet 1998;352:837-851.
18. The American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1994;17(Suppl):616-23.
19. The American Diabetes Association. Executive Summary: Standards of medical care in diabetes. Diabetes Care 2008;31(Suppl):S5-S11.
20. ACE /AACE Diabetes Road Map Task Force. Road maps to achieve glycemic control in type 2 diabetes mellitus. Endocr Pract 2007;13:260-268.
21. Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK; Clinical Efficacy Assessment Subccommittee of the American College of Physicians. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statemment from the American College of Physicians. Ann Intern Med. 2007 Sep 18;147(6):417-22.
22. Harris SB, Lank CN. Recommendations from the Canadian Diabetes Association. 2003 guidellines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician 2004;50:425-33.
23. Miedema K. Towards worldwide standardiization of HbA1c determination. Diabetologia 2004;47:1143-48.
24. Little R, Rohlfing C, Wiedmeyer H, Myers G, Sacks D, Goldstein D, for the NGSP Steering Commmittee. The National Glycohemoglobin Standardiization Program: A five-year progress report. Cliniccal Chemistry 2001;47:1985-92.
25. Jeppsson J-O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin A1c by a new liquid chromatographic assay: methodology, clinical utility and relation to glucose tolerance evaluated. Clinic Chem 1986;32:1867-72.
26. Hoshino T, Okahashi M, Arai H. Survery and assessment of the actual state of routine meassurement of glycohemoglobin/GH b by commercial methods: warning to users and the providers. J Pharm Biomed Anal1997;15:1555-62.
27. Hoelzel W, Weykamp C, Jeppsson Jo, Mieedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, et al. IFCC Working Group on HbA1c standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A methodcomparison study. Clinic Chem 2004;50:166-174.
28. Weykamp CW, Penders TJ, Muskiet FA, van der Slik W. Influence of haemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methoods. Clini Chem 1993; 39:1717-23.
29. Gunton J, McElduff A. Hemoglobinopathies and HbA1c measurement. Diabetes Care 2000; 23: 1197-8.
30. Koskinen L, Ala-Houhala I, Lahtela J, Laippala P, Koivula T. Does uremia interfere with HbA1c results in the FPLC method with mono S cation excchanger? Clinica Chemica Acta 1998; 273: 69-79.
31. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007 Oct;30(10):2453-7. Epub 2007 May 29.
32. Saunders AM. Glycosylated hemoglobin as a diagnostic test for Type 2 diabetes mellitus (Lettters). JAMA 2000;283;606.
33. HbA1c and hemoglobin variants (HbS and HbC traits). The NGSP Website. [accessed 16 Decembber 2007]. Available from: http://www.ngsp.org/prog/hbsandc. htm.
34. Manufacturer's pamphlet on the Roche/Hitachi (r) HB A1C II (Tina-quant (r) [a] Hemoglobin A1c II) turbidimetric inhibition immunoassay analyzer. 2001.
35. Panteghini M, John WG. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45:942-944.
36. Consensus Committee. Consensus statement on the worldwide standardization of the hemogglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the Internnational Diabetes Federation. Diabetes Care. 2007 Sep;30(9):2399-400.
37. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. A1c-Derived Average Glucose Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008;31:1704-7.
38. Tucker M. Equation ties HbA1c to average blood glucose. Endocrinology Clinical Rounds. Intternal Medicine News 2007 November 1st. 25 p.
39. Svendson PA, Lauritzen T, Soegaard U, Nerup J. Glycosylated haemoglobin and steady-state mean blood glocsoe concentration in type 1 (insulin- deppenedent) diabetes. Diabetlogia 1982;23:403-405.
40. Nathan DM, Singer DE, Hurxthal K, Goodsson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-346.
41. Diabetes Control and Complications Trial (DCC T): results of feasibility study. The DCC T Research Group. Diabetes Care. 1987 Jan- Feb;10(1):1-19.
42. Rohlfing C, Wiedmeyer H, Little R, England J, Tennill A, Goldsetin D. Defining the relationship bettween plasma glucose and HbA1c. Diabetes Care 2002;25:275-278.
43. Rohlfing C, Little R, Wiedmeyer H, England J, Madsen R, Harris M, Flegal K, Eberhardt M, Goldssetin D. Use of GH b (HbA1c) in screening for undiaagnosed diabetes in the US population. Diabetes Care 2000;23:187-191.
44. Buell C, Kermah D, Davidson MB. Utility of A1c for diabetes screening in the 1999-204 NHANES population. Diabetes Care 2007;30(9):2233-5.
45. Santiago JV, Davis JE, Fisher F. Hemoglobin A1c levels in a diabetes detection program. J Clin Endocrinol Metab 1978;47:578-80.
46. Dods RF, Bolmey C. Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus. Clin Chem 1979;25:764-68.
47. Simon D, Coignet MC, Thibult N, Senan C, Eschwege E. Comparison of glycosylated hemogglobin and fasting plasma glucose with two-hour postload plasma glucose in the detection of diabettes mellitus. Am J Epidemiol 1985;122:589-593.
48. Little RR, England JD, Wiedmeyer HM, McKeenzie EM, Pttitt DJ, Knowler WC, Goldstein DE. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening. Diabetes 1988;37:60-64.
49. McCance DR, Hanson RL, Charles MA, Jackobsson LTH, Pettit DJ, Bennett PH, Knowler WC. Compparison of tests for glycated hemoglobin and fastiing and two hour plasma glucose concentrations as diagnostic methods. BMJ 1994;308:1323-28.
50. Peters A, Davidson MB, Schriger D, Hasselblad V, for the Meta-analysis Research Group on the Diaabgonsis of Diabetes Using Glycated Hemoglobin Levels. A clincial Approach for the diagonosis of diabetes mellitus. JAMA 1996;276:1246-52
51. Ko GT, Chan JC, Cockram CS. Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes. Diabetes Care 1998;21:2032-3.
52. Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito C, Kadowaki T. Prevalence of diabetes estimated by plasma glucose criteria combined with standdardized measurement of HbA1c among health checkup participants on Myako Island, Japan. Diabetes Care 2000;23:1092-6
53. Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, twohour plasma glucose and HbA1c. Diabetes Res Clin Practice 2000;50:225-230.
54. Perry RC, Shankar RR, Finerberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuaals with nondiagnostic levelsl of fasting plasma glucose. The early diabetes intervention program (EDIP). Diabetes Care 2001;24:465-71.
55. Edelman D. Outpatient diagnostic errors: unrecognized hyperglycemia. Eff Clin Pract 2002;5:11-6.
56. Edelman D, Edwards LJ, Olsen MK, Dudley TK, Harris AC, Blackwell DK, Oddone EZ. Screening for diabetes in an outpatient clinic population. J Gen Intern Med 2002;17:23-8.
57. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H. Utilitiy of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003;26:1064-8.
58. Davidson MB, Shriger DL, Peters AL, Lorber B Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for falsepositive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281:1203-10.
59. Anand S, Razak F, Vuksam V, Gerstein H, Malmbberg K, Quilong Y, Teo K, Yusuf S. Diagnostic strateegies to detect glucose intolerance in a multiethnnic population. Diabetes Care 2003;26:290-6.
60. Silverman RA, Pahk R, Carbone M, Wells E, Mitzner R, Burris K, Kelson JR, Grella R, Katzeff H. The relationship of glucose and HbA1c levels among emergency department patients with no prior history of diabetes mellitus. Acad Emerg Med 2006;13:722-6.
61. Suwazono Y, Sakata K, Okubo Y, Harada H, Oishi M, Kobayashi E, Uetani M, Kido T, Nogawa K. Long-term longitudinal study on the relationsship between alternating shift work and the onset of diabetes mellitus in male Japanese workers. Journal of Occumpational and Environmental Medicine 2006;48:455-461.
62. Pollak A, Brehm R, Havelec L, Lubec G, Malamitsi-Puchner A, Simbrunner G, Widness JA. Total glycosylated hemoglobin in mothers of largefor- gestational-age infants: a postpartum test for undetected maternal diabetes. Biol Neonate 1981; 40:129-35.
63. Shah BD, Cohen AW, May C, Gabbe SG. Compparison of glycohemoglobin determination and one-hour oral glucose screen in the identification of gestational diabetes. Am J Obstet Gynecol 1982; 144: 774-7.
64. Artal R, Artal R Mosley GM, Dorey FJ. Glycohemmoglobin as a screening test for gestational diabbetes. Am J Obstet Gynecol 1984; 148: 412-4.
65. Cousins L, Dattel BJ, Hollingsworth Dr. Zetner A. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. Am J Obstet Gyne 1984; 150:455-60.
66. Frisoli G, Naranjo L, Shehab N. Glycohemoglobbin in normal and diabetic pregnancy. Am J Perinnatol 1985; 2: 183-8.
67. Cocilovo G, Guerra S, Colla F, Tomasi F. Glycossylated hemoglobin (HbA1) assays a test for dettection and surveillance of gestational diabetes. Diabetes Metab 1987; 13: 426-30.
68. Griffith RJ, Vinall PS, Stickland MH, Wales JK. Hemoglobin A1c in normal and diabetic pregnanccies. Eur J Obstet Gynecol Reprod Biol 1987; 24: 195-200.
69. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M, Thomas L. Gestational diabetes screening of a multi-ethnic, high-risk population using glycated proteins. Diabetes Res Clin Pract 2001; 51: 67-73.
70. Agarwal M, Dhatt G, Punnose J, Koster G. Gestational diabetes: A reappraisal of HB A1c as a screening test. Acta Obstet Gynecol Scand 2005; 84: 1159-63.
71. Aldasouqi S, Solomon D, Bokhari S, Khan M, Shareef M. Glycohemoglobin A1c is a promising diagnostic tool in gestational diabetes mellitus. A pilot retrospective study. Endocr Pract 2006;12 (Suppl): 8. A-113.
72. Ealovega M, Tabaei B, Brandle M, Burke R, Herman W. Opportunistic screening for diabettes in routine clinical practice. Diabetes Care 2004;27:9-12.
73. The USPSTF. Screening for type 2 diabetes mellitus in adults: Recommendations and rattionale. Annals of Internal Medicine 2003; 138: 212-4.
74. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classificattion of diabetes provisional report a WHO consulttation. Diabetes Medicine 1998; 15: 539-53.
75. Leeuwen M, Zweers E, Opmeer B, Ballegooie E, Brugge H, Valk H, Mol B, Visser G. Comparison of accuracy of two screening tests for gestationaal diabetes mellitus. Diabetes Care 2007;30:2779- 2784.
76. Aldasouqi S, Solomon D, Bokhari S, Khan M, Shareef M, Gossain V. Glycohemoglobin A1c is a promising screening tool in gestational diabetes mellitus. Forthcoming.
77. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemian for the diagnosis of type 2 diabetes mellitus. Annal Intern Med 2002;137:263- 272.
78. Thaler LM, Dunbar VG, Ziemer DC, Phillips LS, Gallina DL, El-Kebbi IM, Cook CB : Diabetes in urbban African-Americans. XVII Availability of rapid HbA1c measurements enhances clinical decision making. Diabetes Care 1999; 22:1415-1421.
79. Cagliero E, Levina EV, Nathan DM. Immediaate feedback of HbA1c levels improves glycemic control in type 1 and insulin treated type 2 diabbetic patients. Diabetes Care 1999; 22: 1785-1789.
80. Ferenczi A, Reddy K, Lorber DL. Effect of immmediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract 2001; 7:85-88.
81. Mattewal A, Aldasouqi S, Solomon D, Gosssain V, Koller. A simple method for office-based glycohemoglobin measurement. Diab J Scien Technolo 2007;1(6):879-884.
82. The 2007 NGSP Clinical Advisory Committee Meeting. The American Diabetes Association 67th Annual Scientific Sessions. 2007 June 2007. [accessed 23 December 2007]. Available from: http://ngsp.org/prog/News/CAC2007.htm.